Post-approval studies (Phase 4)Study completedNCT00140621
What this trial is testing
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 6